Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Study to evaluate the safety profile of Secotex® in the improvement of the symptoms of Benign Prostatic Hyperplasia in real clinical practice

Boehringer Ingelheim